Nektar Therapeutics (NKTR)

Price$41.69 (February 15th, 2019)
Sector: Healthcare
Description:Nektar Therapeutics Inc is a biopharmaceutical company engaged in the development of new molecules to treat diseases with unmet medical needs. The company is researching and developing drugs for treating cancer, auto-immune disease and chronic pain.
Current Rating: 69

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice.